CSL Limited (CSLLY)
OTCMKTS · Delayed Price · Currency is USD
25.66
+0.22 (0.85%)
At close: Mar 10, 2026
CSL Limited Market Cap
CSL Limited has a market cap or net worth of $49.67 billion as of March 10, 2026. Its market cap has decreased by -38.72% in one year.
Market Cap
49.67B
Enterprise Value
62.30B
Revenue
15.41B
Ranking
n/a
PE Ratio
35.58
Stock Price
$25.66
Market Cap Chart
Since June 2, 1994, CSL Limited's market cap has increased from 230.16M to 49.67B, an increase of 21,479.61%. That is a compound annual growth rate of 18.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 49.02B | -11.71% |
| Dec 31, 2025 | 55.52B | -34.20% |
| Dec 31, 2024 | 84.38B | -10.61% |
| Dec 29, 2023 | 94.40B | 0.09% |
| Dec 30, 2022 | 94.31B | -6.81% |
| Dec 31, 2021 | 101.20B | 1.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 360.57M |
| CytoDyn | 296.04M |
| Silence Therapeutics | 294.27M |
| Vaxart | 177.30M |
| HST Global | 88.40M |
| BioStem Technologies | 87.58M |
| Nuo Therapeutics | 60.36M |
| Vicapsys Life Sciences | 48.56M |